Health & Biotech
Check out the latest COVID-19 and Coronavirus news, insights and unique analysis brought to you by Stockhead’s team of business journalists and industry experts.
News
WFH is here to stay. But which ASX stocks will stay to benefit?
Health & Biotech
Awareness of the Pfizer vaccine in Australia could unlock a new health investment trend, says one VC
News
Oil will surge 19pc and copper will see double-digit returns over the next 6 months, Goldman says
Health & Biotech
Here’s why the COVID-induced telehealth boom is only just beginning
Health & Biotech
COVID-19 study using Dimerix drug compound recruits patients in Europe
IPO Watch
IPO Watch: $2.6b lender Latitude Financial lists on the ASX; gains another 15pc on debut
News
Hong Kong domiciled penny stock Merchant House nearly triples after US$20m factory sale
Health & Biotech
Skin Elements to launch its ‘game-changing’ COVID-19 spray Invisi Shield, after signing off a new $20 million equity facility
News
ASX investors are increasingly relying on each other for financial advice
News
A wave of corporate insolvencies might be coming; but it could be good news for these ASX stocks
Health & Biotech
AstraZeneca rollout in jeopardy? The ASX’s COVID vaccine maker and wannabe seem immune
News
Jayride rockets by 76 per cent, as ASX travel stocks rise on travel bubbles
News
As people return to the office, these are the ASX shares set to benefit
News
Cleanspace halves after revealing a drop in North American sales
Experts
MoneyTalks: Which ASX retail stocks are safe from Amazon and which ones are vulnerable?
Tech
Telehealth Oneview rises by 400pc in two weeks; how will other ASX wellness stocks play out post-COVID?
Health & Biotech
Stock of the day: Nanoveu goes truly global after coffee deal with Nestle, share price shoots 90pc
News
These ASX small caps are rated by IBISWorld among Australia’s top 1000 companies
News
There’s only one ASX stock involved in the COVID vaccine rollout right now; and it’s just dispatched the first doses
Health & Biotech
COVID-19 has hit the global dentist industry but these ASX stocks are doing fine
Health & Biotech
1 in 10 COVID survivors in Britain still suffer symptoms; ASX cannabis stock Bod wants to help
News
Here’s how Australia’s housing market could slow down even without interest rates rising
News
Here are the 10 best ASX stocks since COVID-19 began; they’re up over 2000pc
Health & Biotech
AstraZeneca’s COVID-19 fight hits the skids; ASX small cap Biotron says ‘We’re on track’
Health & Biotech
Global CLARITY 2.0 study gets key approval from Indian regulators for clinical COVID-19 study, Dimerix shares jump
News
Capital Raisings Recap: 2021 has begun with a bang with nearly $2bn raised
Director Trades
Directors Trades: The sellers outnumbered the buyers by nearly 10 times
IPO Watch
IPO Watch: My Food Bag becomes latest meal kit delivery stock to list on the ASX; but shares fall
News
The best ASX stock on ESG has just cracked the world’s top five
Food & Agriculture
These 2 ASX seafood stocks have more than doubled in 12 months despite COVID-19
Aftermarket
How I earned more than 200,000 Qantas Points despite COVID
Health & Biotech
eSense making progress on revolutionary hand sanitiser product
News
Share investing is becoming more popular in Australia; and these platforms could benefit
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
Tech
Demand for ‘tech that works’ could put these ASX stocks under pressure in 2021
Health & Biotech
So, COVID vaccines are here; what now for all those biotechs working on COVID 19 drugs or tests?
News
Half Yearlies Top 5: McGrath is the ASX’s top lodger this morning
News
The Morrison government will allow virtual AGMs for another six months
Guides
Explainer: What is a ‘sophisticated investor’ and what doors open when you become one?
Stockhead TV
Post-pandemic winners – who’s taking advantage in the new normal?
Tech
Amazon just passed $1bn in revenue in Australia; are ASX retail and ecommerce stocks under threat?
Health & Biotech
HealthKick Podcast: NSB brings new solutions to medicine’s most stubborn eye problems
Health & Biotech
CLARITY 2.0 study could unlock ‘exciting’ potential of Dimerix drug candidate DMX-200 as a COVID-19 treatment
Health & Biotech
COVID-19 isn’t stopping ASX health stocks’ ambitions to make it in Europe and the US
News
Unemployment in Australia dropped further in December; but ‘challenges remain’ for the economy
News
ASX construction stocks are on the rebound thanks to a $50bn-powered boom
Food & Agriculture
Cannabis stock Australian Primary Hemp wins Woolworths supply deal
Load More
